Lancet Diabetes Endocrinol 8:880893
Related guides Switching From Wegovy to Zepbound: The Evidence-Based Transition Protocol and Dose Conversion Guide Switching from Zepbound to Wegovy: The Dose Conversion Protocol, Timeline, and Why the Transition Isn't 1:1 Switching from Zepbound to Wegovy: The Complete Protocol for a Safe, Effective Transition Switching from Wegovy to Zepbound: The Dose Conversion Protocol That Minimizes Side Effects Switching from Wegovy 2.4 mg to Zepbound: The Dose Conversion Protocol That Actually Works Wegovy to Zepbound Conversion: The Dose Translation Protocol and What to Expect When Switching Tool: dosage calculator Sources Jastreboff AM et al
DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation
This distinguishes it from oral medications, where fibre can sometimes bind to drug molecules or alter absorption rates
Patients who stop taking Ozempic or Wegovy often gain their weight back relatively quickly
When to Seek Professional Guidance If you have underlying health conditions such as thyroid disorders, diabetes, or hormonal imbalances or if weight loss has plateaued, professional support is vital
